Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Non-Current Assets (2016 - 2024)

Historic Non-Current Assets for Sanofi (SNY) over the last 17 years, with Q3 2025 value amounting to $111.9 billion.

  • Sanofi's Non-Current Assets changed N/A to $111.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $111.9 billion, marking a year-over-year change of. This contributed to the annual value of $96.4 billion for FY2024, which is 697.16% down from last year.
  • According to the latest figures from Q3 2025, Sanofi's Non-Current Assets is $111.9 billion.
  • In the past 5 years, Sanofi's Non-Current Assets registered a high of $111.9 billion during Q3 2025, and its lowest value of $92.4 billion during Q1 2025.
  • In the last 5 years, Sanofi's Non-Current Assets had a median value of $99.6 billion in 2021 and averaged $100.9 billion.
  • Per our database at Business Quant, Sanofi's Non-Current Assets soared by 1175.22% in 2021 and then plummeted by 780.69% in 2022.
  • Over the past 5 years, Sanofi's Non-Current Assets (Quarter) stood at $102.5 billion in 2021, then decreased by 7.81% to $94.5 billion in 2022, then rose by 9.08% to $103.1 billion in 2023, then decreased by 6.47% to $96.4 billion in 2024, then grew by 16.12% to $111.9 billion in 2025.
  • Its Non-Current Assets was $111.9 billion in Q3 2025, compared to $99.5 billion in Q2 2025 and $92.4 billion in Q1 2025.